| Literature DB >> 26344293 |
Paola Aline Amarante Borba1, Marihá Pinotti1, George Ricardo Santana Andrade2, Nivan Bezerra da Costa3, Luiz Renato Olchanheski Junior4, Daniel Fernandes4, Carlos Eduardo Maduro de Campos5, Hellen Karine Stulzer6.
Abstract
Telmisartan (TEL) was entrapped into β-cyclodextrin aiming the improvement of its biopharmaceutical properties of low solubility. A solid state grinding process was used to prepare the molecular inclusion complex (MIC) for up to 30min. The inclusion ratio of drug and β-cyclodextrin was established as 1:2 and 1:3 (mol/mol) by phase solubility study and Job Plot. DSC, XRPD and FTIR confirmed the molecular interactions between TEL and β-cyclodextrin. Computer molecular modeling supports the presence of hydrogen bonds between guest and host and demonstrated the most probable complexes configuration. MIC_1:2_30 and MIC_1:3_30 enhanced the dissolution rate of the drug achieving a delivery rate comparable with the reference medicine available in the market (81% and 87% in 5min, for MIC_1:3_30 and Micardis(®), respectively). These formulations showed rapid and effective antihypertensive effect against angiotensin II in rats up to 180min, with statistically significant results against placebo and control in the first 30min after administration.Entities:
Keywords: In vivo studies; Mechanical grinding process; Molecular inclusion complex; Molecular modeling; Telmisartan; β-Cyclodextrin
Mesh:
Substances:
Year: 2015 PMID: 26344293 DOI: 10.1016/j.carbpol.2015.06.098
Source DB: PubMed Journal: Carbohydr Polym ISSN: 0144-8617 Impact factor: 9.381